Zawitz David bought VRCA
November 25, 2025 · Form 4 insider transaction
Zawitz David bought 10,000 shares of Verrica Pharmaceuticals Inc. at $4.24 per share, a transaction worth $42.4K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$4.24
Total value
$42.4K
InsiderZawitz David
RoleOfficer
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 25, 2025
Filing dateNovember 25, 2025
Shares owned after21,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.